PRESS RELEASE
Published August 11, 2023
Table of Contents
IMARC Group, a leading market research company, has recently releases report titled “COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the global COPD and asthma devices market trends, share, size, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of COPD and Asthma Devices Market
Devices tailored for Chronic Obstructive Pulmonary Disease (COPD) and asthma serve as specialized medical instruments designed to support individuals grappling with respiratory conditions. This category encompasses inhalers, nebulizers, peak flow meters, and spacers. Inhalers, in particular, administer medication directly into the lungs, providing immediate relief during asthma attacks or episodes of exacerbated COPD symptoms. These devices contribute to symptom management, the enhancement of lung function, and mitigation of issues like shortness of breath, wheezing, and chest tightness. Consequently, patients experience improved ease of breathing, greater comfort, and an enhanced overall quality of life. Notably, by facilitating improved airflow, heightened oxygen intake, and enhanced respiratory performance, the demand for COPD and asthma devices is witnessing a global upsurge.
How Big Is the COPD and Asthma Devices Market?
The global COPD and asthma devices market size reached US$ 43.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 60.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028.
Request a free sample of report: www.imarcgroup.com/copd-asthma-devices-market/requestsample
Global Industry Trends and Drivers:
The expanding geriatric population who are highly susceptible to chronic respiratory disorders is primarily driving the COPD and asthma devices market. Additionally, the emerging trend of automation in the healthcare industry is further bolstering the market growth. Besides this, the increasing air pollution levels and the growing prevalence of breathing problems are acting as significant growth-inducing factors. Moreover, the widespread adoption of connected medical devices among healthcare professionals to allow patients to receive the best care and consultation possible is positively influencing the global market. Apart from this, the development of more efficient and effective COPD and asthma devices to improve the efficiency of medication management is also stimulating the market growth. Furthermore, the launch of favorable reimbursement schemes by government bodies offered by health insurance companies is anticipated to fuel the COPD and asthma devices market over the forecasted period.
What Is Included In Market Segmentation?
The report has been segmented the market into following categories:
Breakup by Product:
- Inhalers
- Drug Powdered Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers
- Nebulizers
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Breakup by Indication:
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospitals
- Online Pharmacies
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
The report provides a comprehensive analysis of the industry key players listed below:
Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.
Ask Analyst for 10% free customized report: www.imarcgroup.com/request?type=report&id=6126&flag=C
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
